In vitro binding of a Herpesvirus ateles (HVA)associated soluble antigen to amphibian erythrocyte nuclei was demonstrated by the acid-fixed nuclear binding technique in combination with anticomplement immunofluorescence. Incubation of concentrated salt-extracted soluble antigens derived from HVA-carrying marmoset lines with methanol/acetic acid-fixed erythrocytes of frogs and salamanders resulted in a brilliant nuclear fluorescence after exposure to a live virus-boostered, anti-HVS-positive squirrel monkey serum. Anti-HVS-negative sera did not stain. Although antibodies to early and late viral antigens have been demonstrated in the HVS system (15), the search for a nuclear antigen by the ACIF technique has been fruitless so far. In our earlier (unpublished) experiments, extensive application of this technique to HVS-and HVA-carrying cell lines produced negative results. We have used the sera of normal, HVS-seropositive squirrel monkeys and of marmosets with progressive HVS-induced lymphoproliferative disease.
Transforming and oncogenic DNA viruses induce DNAbinding nuclear antigens that are believed to play a key role in transformation (1) . This is particularly clear for the simian virus 40 T antigen that is found in the nucleus of all virally infected cells and binds preferentially to a specific sequence of the simian virus 40 DNA molecule close to or at the site for initiation of viral DNA synthesis (2, 3) .
Induction of nuclear antigens is not restricted to the small transforming DNA viruses. Epstein-Barr virus (EBV) induces a nuclear antigen (EBNA) in all transformed cells, including Burkitt lymphoma, nasopharyngeal carcinoma, and in vitro transformed lymphoblastoid cell lines (4) . Because oncogenic RNA viruses do not induce T-type antigens, in contrast to the regular appearance and probable transforming role of T-type antigens in the DNA virus systems, it is important to explore the question of whether all known transforming DNA viruses induce DNA-binding nuclear antigens. Previously, we have approached this question by using an EBV-related baboon lymphotropic herpesvirus (Herpesvirus papio, HVP) system. Although HVP has a partial homology with EBV at the DNA level and produces crossreactive early and viral capsid antigens (5), the sensitive anticomplement immunofluorescence (ACIF) technique (4) failed to detect an EBNA-like nuclear antigen. We have found that a nuclear antigen can be demonstrated by an amplification technique, designated "acid-fixed nuclear binding (AFNB)" (6) . The technique is based on the extraction of DNA-binding proteins, incubation with acid-fixed erythrocyte nuclei, and subsequent ACIF staining. The HVP-determined antigen was designated HUPNA (6) . EBNA and HUPNA were similar in their DNA-binding properties and showed partial serological crossreactivity (7, 8 Preparation of Cell Extracts. One hundred microliters of washing buffer (0.15 M NaCl/20 mM Tris-HCI, pH 7.4/1 mM EDTA/1 mM 2-mercaptoethanol/0.5 mM phenylmethylsulfonyl fluoride) was added to cell pellets containing 108 cells, frozen-thawed three times, and centrifuged at 8000 X g for 30 min at 4°C. Crude supernatants were used for the nuclear binding experiments. In some experiments, partially purified extracts were tested as well. We followed our procedure (17, 18) (19) . Antigens were prepared from HVA-transformed cells 1022 and 4156HVA. They were tested for AFNB by using the 16300 serum reagent. As shown in Table  1 , the reactions were most brilliant with SaIRBC and least brilliant with CRBC. Pretreatment with 0.6 M NaCl increased the fluorescence. Nuclear staining by AFNB was demonstrated with three target cells (Fig. 1) 
DISCUSSION
These findings show that a DNA-binding, presumably nuclear, antigen exists in certain HVA-carrying cell lines. In contrast to our previous unsuccessful efforts to demonstrate this antigen (unpublished), the present experiments were successful mainly for two reasons: the use of amphibian, rather than chicken, erythrocytes, which contain large amounts of DNA (average 
